Aurinia Pharmaceuticals (AUPH) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 8

One insider bought $12.5M, 1 sold $546K.

SellStephen P. Robertson$190KChief Legal Officerat $15.95 on Sep 10, filed Sep 11

SellStephen P. RobertsonChief Legal Officer$190Kat $15.95 on Sep 10, filed Sep 11

SellStephen P. Robertson$356KChief Legal Officerat $16.97 on Aug 21, filed Aug 25

SellStephen P. RobertsonChief Legal Officer$356Kat $16.97 on Aug 21, filed Aug 25

BuyKevin Tang$5.2MChief Executive Officerat $15.28 on Jun 1, filed Jun 2

BuyKevin TangChief Executive Officer$5.2Mat $15.28 on Jun 1, filed Jun 2

From SEC Form 4s, the newest filed Sep 11, 2026 · Insiders have 2 business days to file a trade

4 more filings on AUPH in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 7 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on AUPH with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Aurinia Pharmaceuticals

Kevin TangChief Executive Officer · 3 buys
Kevin TangChief Executive Officer · 2 buys
Stephen P. RobertsonChief Legal Officer · 2 sales

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about AUPH's insider trades

As of Nov 2, 2026: Aurinia Pharmaceuticals (AUPH) has 7 insider filings on record in the last 6 months, the newest filed Sep 11, 2026. Its Quality Score is 8 (Average). Scores as of 9:30 PM ET, 15 minutes behind.

Are AUPH insiders buying or selling?

One insider bought $12.5M across 5 filings, and one insider sold $546K across 2 filings, in the last 6 months. The newest filing: Stephen P. Robertson, Chief Legal Officer, sold $190K on Sep 10, 2026.

Who are AUPH's biggest insider sellers?

The one insider who sold AUPH in the last 6 months: Stephen P. Robertson (Chief Legal Officer), 2 sales.

When did an AUPH insider last buy?

Kevin Tang, Chief Executive Officer, bought AUPH shares ($5.2M) on Jun 1, 2026, filed Jun 2, 2026, the newest insider buy on record.

Aurinia Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.